MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase 1 ...

Contains nicotine. Nicotine is an addictive substance. For adult nicotine users only. UPPSALA, Sweden, (GLOBE NEWSWIRE) -- ...

Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

Roflumilast 0.05% cream, a phosphodiesterase 4 inhibitor, was approved by the FDA on October 6, having been specifically ...

In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...

Olivares-Tirado, P. (2025) The Mediating Role of Hypnotic Medication in the Association between Sleep Disturbances and Instrumental Activities of Daily Living in Community-Dwelling Brazilian Older ...

The polyamines are present in virtually all cells, prokaryotic or eukaryotic. Their biosynthesis and metabolism are highly regulated and unique active cellular transporters exist. They are known to be ...

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...

Pharmaceutical Market, Artificial Intelligence, Personalized Medicine, Digital Transformation, Supply Chains, Regulatory ...